1. Home
  2. RVPH vs SLNG Comparison

RVPH vs SLNG Comparison

Compare RVPH & SLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • SLNG
  • Stock Information
  • Founded
  • RVPH 2006
  • SLNG 2013
  • Country
  • RVPH United States
  • SLNG United States
  • Employees
  • RVPH N/A
  • SLNG N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • SLNG Oil/Gas Transmission
  • Sector
  • RVPH Health Care
  • SLNG Utilities
  • Exchange
  • RVPH Nasdaq
  • SLNG Nasdaq
  • Market Cap
  • RVPH 88.0M
  • SLNG 85.4M
  • IPO Year
  • RVPH N/A
  • SLNG N/A
  • Fundamental
  • Price
  • RVPH $2.09
  • SLNG $5.95
  • Analyst Decision
  • RVPH Strong Buy
  • SLNG
  • Analyst Count
  • RVPH 5
  • SLNG 0
  • Target Price
  • RVPH $11.40
  • SLNG N/A
  • AVG Volume (30 Days)
  • RVPH 1.8M
  • SLNG 22.3K
  • Earning Date
  • RVPH 11-14-2024
  • SLNG 03-05-2025
  • Dividend Yield
  • RVPH N/A
  • SLNG N/A
  • EPS Growth
  • RVPH N/A
  • SLNG N/A
  • EPS
  • RVPH N/A
  • SLNG 0.21
  • Revenue
  • RVPH N/A
  • SLNG $74,044,000.00
  • Revenue This Year
  • RVPH N/A
  • SLNG N/A
  • Revenue Next Year
  • RVPH N/A
  • SLNG N/A
  • P/E Ratio
  • RVPH N/A
  • SLNG $30.04
  • Revenue Growth
  • RVPH N/A
  • SLNG N/A
  • 52 Week Low
  • RVPH $0.60
  • SLNG $3.77
  • 52 Week High
  • RVPH $4.83
  • SLNG $7.93
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 60.41
  • SLNG 44.73
  • Support Level
  • RVPH $1.78
  • SLNG $5.64
  • Resistance Level
  • RVPH $2.15
  • SLNG $7.79
  • Average True Range (ATR)
  • RVPH 0.15
  • SLNG 0.63
  • MACD
  • RVPH 0.02
  • SLNG -0.14
  • Stochastic Oscillator
  • RVPH 88.30
  • SLNG 22.71

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

Share on Social Networks: